Major 5'terminally deleted enterovirus populations modulate type I IFN response in acute myocarditis patients and in human cultured cardiomyocytes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 07 2020
Historique:
received: 27 02 2020
accepted: 15 05 2020
entrez: 21 7 2020
pubmed: 21 7 2020
medline: 22 12 2020
Statut: epublish

Résumé

Major 5'terminally deleted (5'TD) group-B enterovirus (EV-B) populations were identified in heart biopsies of patients with fulminant myocarditis or dilated cardiomyopathy suggesting that these 5'TD forms are key drivers of host-cell interaction in EV cardiac infections. To date, early emergence of EV-B 5'TD forms and its impact on type 1 IFN response during acute myocarditis remains unknown. Using quantitative RACE-PCR assay, we identified major EV-B 5'TD RNA populations in plasma or heart samples of acute myocarditis cases. Deletions identified within the 5' non-coding region of EV-B populations only affected secondary-structural elements of genomic RNA domain I and were distinguished in two major groups based on the extent of RNA structural deletions. Proportions of these two respective EV-B 5'TD population groups were positively or negatively correlated with IFN-β levels in plasma samples of myocarditis patients. Transfection of synthetic CVB3/28 RNAs harboring various 5'terminal full-length or deleted sequences into human cultured cardiomyocytes demonstrated that viral genomic RNA domain I possessed essential immunomodulatory secondary-structural elements responsible for IFN-β pathway induction. Overall, our results highlight the early emergence of major EVB-TD populations which deletions affecting secondary-structures of RNA domain I can modulate innate immune sensing mechanisms in cardiomyocytes of patients with acute myocarditis.

Identifiants

pubmed: 32686697
doi: 10.1038/s41598-020-67648-5
pii: 10.1038/s41598-020-67648-5
pmc: PMC7371739
doi:

Substances chimiques

5' Untranslated Regions 0
Interferon Type I 0
RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11947

Investigateurs

A Mirand (A)
C Henquell (C)
Marie-Laure Mathieu (ML)
Ellia Mezgueldi (E)
Matthieu Verdan (M)
Pascal Motreff (P)
B Lina (B)
I Schuffenecker (I)
Samira Fafi-Kremer (S)
Quentin Lepiller (Q)
Patrick Bruneval (P)

Références

Dennert, R., Crijns, H. J. & Heymans, S. Acute viral myocarditis. Eur. Heart J.29, 2073–2082 (2008).
doi: 10.1093/eurheartj/ehn296
Pallansch, M. A. & Roos, R. Enteroviruses : Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. In Fields Virology Vol. 1 840–893 (Lippincott William & Wilkens Company, 2007).
Racaniello, V. R. Picornaviridae: the viruses and their replication. In Fields Virology Vol. 1 795–838 (Knipe & Howley, 2007).
Chapman, N. M., Kim, K.-S., Drescher, K. M., Oka, K. & Tracy, S. 5’ terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology375, 480–491 (2008).
doi: 10.1016/j.virol.2008.02.030
Kim, K.-S. et al. 5’-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J. Virol.79, 7024–7041 (2005).
doi: 10.1128/JVI.79.11.7024-7041.2005
Kim, K.-S., Chapman, N. M. & Tracy, S. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J. Virol.82, 2033–2037 (2008).
doi: 10.1128/JVI.01774-07
Bouin, A. et al. Major persistent 5′ terminally deleted coxsackievirus B3 populations in human endomyocardial tissues. Emerg. Infect. Dis.22, 1488–1490 (2016).
doi: 10.3201/eid2208.160186
Bouin, A. et al. Enterovirus persistence in cardiac cells of patients with idiopathic dilated cardiomyopathy is linked to 5’ terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities. Circulation139, 2326–2338 (2019).
doi: 10.1161/CIRCULATIONAHA.118.035966
Feng, Q. et al. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep.2, 1187–1196 (2012).
doi: 10.1016/j.celrep.2012.10.005
Feng, Q. et al. Coxsackievirus cloverleaf RNA containing a 5′ triphosphate triggers an antiviral response via RIG-I activation. PLoS ONE9, e95927 (2014).
doi: 10.1371/journal.pone.0095927
Lévêque, N. et al. Functional Consequences of RNA 5′-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation. J. Virol.91, (2017).
Ertel, K. J., Brunner, J. E. & Semler, B. L. Mechanistic consequences of hnRNP C binding to both RNA termini of poliovirus negative-strand RNA intermediates. J. Virol.84, 4229–4242 (2010).
doi: 10.1128/JVI.02198-09
Brunner, J. E., Ertel, K. J., Rozovics, J. M. & Semler, B. L. Delayed kinetics of poliovirus RNA synthesis in a human cell line with reduced levels of hnRNP C proteins. Virology400, 240–247 (2010).
doi: 10.1016/j.virol.2010.01.031
Jaramillo, L., Smithee, S., Tracy, S. & Chapman, N. M. Domain I of the 5′ non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication. Virology496, 127–130 (2016).
doi: 10.1016/j.virol.2016.05.021
Reikine, S., Nguyen, J. B. & Modis, Y. Pattern recognition and signaling mechanisms of RIG-I and MDA5. Fronti Immunol.5, (2014).
Fung, G., Luo, H., Qiu, Y., Yang, D. & McManus, B. Myocarditis. Circ. Res.118, 496–514 (2016).
doi: 10.1161/CIRCRESAHA.115.306573
Lévêque, N. et al. Functional consequences of RNA 5′-terminal deletions on coxsackievirus B3 RNA replication and ribonucleoprotein complex formation. J. Virol.91, e00423-e517 (2017).
doi: 10.1128/JVI.00423-17
Gamarnik, A. V. & Andino, R. Two functional complexes formed by KH domain containing proteins with the 5’ noncoding region of poliovirus RNA. RNA3, 882–892 (1997).
pubmed: 9257647 pmcid: 1369533
Holmblat, B. et al. Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses. mBio5, e01119-14 (2014).
doi: 10.1128/mBio.01119-14
Muslin, C., Joffret, M.-L., Pelletier, I., Blondel, B. & Delpeyroux, F. Evolution and emergence of enteroviruses through intra- and inter-species recombination: plasticity and phenotypic impact of modular genetic exchanges in the 5’ untranslated region. PLoS Pathog.11, e1005266 (2015).
doi: 10.1371/journal.ppat.1005266
Vignuzzi, M. & López, C. B. Defective viral genomes are key drivers of the virus–host interaction. Nat. Microbiol.4, 1075–1087 (2019).
doi: 10.1038/s41564-019-0465-y
Sanchez David, R. Y. et al. Comparative analysis of viral RNA signatures on different RIG-I-like receptors. Elife5, e11275 (2016).
doi: 10.7554/eLife.11275
Caforio, A. L. P. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J.34(2636–2648), 2648a–2648d (2013).
Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol.35, 1547–1549 (2018).
doi: 10.1093/molbev/msy096
Nix, W. A., Oberste, M. S. & Pallansch, M. A. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J. Clin. Microbiol.44, 2698–2704 (2006).
doi: 10.1128/JCM.00542-06
Panaro, N. J. et al. Evaluation of DNA fragment sizing and quantification by the agilent 2100 bioanalyzer. Clin. Chem.46, 1851–1853 (2000).
doi: 10.1093/clinchem/46.11.1851
Nachamkin, I. et al. Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene. J. Clin. Microbiol.39, 754–757 (2001).
doi: 10.1128/JCM.39.2.754-757.2001
Lu, C.-Y., Tso, D.-J., Yang, T., Jong, Y.-J. & Wei, Y.-H. Detection of DNA mutations associated with mitochondrial diseases by Agilent 2100 bioanalyzer. Clin. Chim. Acta 318, 97–105 (2002).
doi: 10.1016/S0009-8981(01)00809-9

Auteurs

M Glenet (M)

University of Reims Champagne-Ardenne and EA4684 Cardiovir Research Laboratory, Reims, France.

Y N'Guyen (Y)

University of Reims Champagne-Ardenne and EA4684 Cardiovir Research Laboratory, Reims, France.
Centre Hospitalier Universitaire de Reims, Reims, France.

A Mirand (A)

National Reference Center of Enterovirus and Parechovirus, Clermont-Ferrand, France.
University of Clermont Auvergne, Clermont-Ferrand, France.
Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France.

C Henquell (C)

National Reference Center of Enterovirus and Parechovirus, Clermont-Ferrand, France.
University of Clermont Auvergne, Clermont-Ferrand, France.
Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France.

A-L Lebreil (AL)

University of Reims Champagne-Ardenne and EA4684 Cardiovir Research Laboratory, Reims, France.

F Berri (F)

University of Reims Champagne-Ardenne and EA4684 Cardiovir Research Laboratory, Reims, France.

F Bani-Sadr (F)

Centre Hospitalier Universitaire de Reims, Reims, France.

B Lina (B)

National Reference Center of Enterovirus and Parechovirus, Lyon, France.
Hospices Civils de Lyon, Lyon, France.
University of Lyon, Lyon, France.

I Schuffenecker (I)

National Reference Center of Enterovirus and Parechovirus, Lyon, France.
Hospices Civils de Lyon, Lyon, France.
University of Lyon, Lyon, France.

L Andreoletti (L)

University of Reims Champagne-Ardenne and EA4684 Cardiovir Research Laboratory, Reims, France. landreoletti@chu-reims.fr.
Centre Hospitalier Universitaire de Reims, Reims, France. landreoletti@chu-reims.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH